Trials / Terminated
TerminatedNCT02228655
An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD
An Exploratory, Uncontrolled, Open-labeled Trial to Evaluate the Effect of FMX-8 Treatment for Anemia in Patients With Chronic Kidney Disease (CKD), Stage 4 or 5
- Status
- Terminated
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- FerruMax Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
FMX-8 is a new type of drug being tested for the treatment of anemia in chronic illnesses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FMX-8 |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-04-01
- Completion
- 2015-07-01
- First posted
- 2014-08-29
- Last updated
- 2016-02-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02228655. Inclusion in this directory is not an endorsement.